CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 46 filers reported holding CATALYST BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,435 | +37.4% | 90,058 | +0.2% | 0.01% | +75.0% |
| Q2 2023 | $31,604 | +69.9% | 89,886 | 0.0% | 0.00% | +100.0% |
| Q1 2023 | $18,606 | -61.0% | 89,886 | -0.7% | 0.00% | -71.4% |
| Q4 2022 | $47,730 | +6.1% | 90,484 | +0.3% | 0.01% | -22.2% |
| Q3 2022 | $45,000 | -72.9% | 90,188 | -3.5% | 0.01% | -78.6% |
| Q2 2022 | $166,000 | +137.1% | 93,434 | -11.9% | 0.04% | +82.6% |
| Q1 2022 | $70,000 | -30.7% | 106,089 | -4.4% | 0.02% | -57.4% |
| Q4 2021 | $101,000 | – | 110,991 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 471,448 | $5,502,000 | 3.04% |
| ACUTA CAPITAL PARTNERS, LLC | 830,000 | $9,686,000 | 1.72% |
| NEXTHERA CAPITAL LP | 786,865 | $9,183,000 | 1.42% |
| Ghost Tree Capital, LLC | 355,000 | $4,143,000 | 1.22% |
| Point72 Europe (London) LLP | 83,500 | $974,000 | 0.52% |
| Virtus ETF Advisers LLC | 31,061 | $362,000 | 0.32% |
| Eventide Asset Management | 246,000 | $2,871,000 | 0.12% |
| Kalos Management, Inc. | 8,500 | $244,000 | 0.11% |
| MARSHALL WACE, LLP | 550,352 | $6,423,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 157,145 | $1,834,000 | 0.09% |